Calithera Biosciences grabs $35 mln in Series D financing
Calithera Biosciences said Tuesday that it has closed $35 million in Series D financing. Adage Capital Partners led the round with participation from the Longwood Fund, Morgenthaler Ventures, Advanced Technology Ventures and Delphi Ventures. Also, Dr. Christoph Westphal, partner and co-founder of the Longwood Fund, joins Calithera's board of directors as an observer. Based in South San Francisco, Calif., Calithera Biosciences is a biotech company that develops cancer therapeutics.
29 October 2013•3 mins read
